Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
CRISPR/Cas9
75%
Factor IX
70%
Genome Editing
64%
Guide RNA
60%
Adeno Associated Virus Vector
55%
Gene Targeting
50%
Cas9
43%
Haemophilia B
43%
Cis-Regulatory Module
41%
CRISPR
35%
Promoter Region
33%
Hepatocyte
32%
Transgene
30%
Haemophilia A
28%
Indel
27%
Tumor-Associated Macrophage
25%
Whole Genome Sequencing
25%
Virus DNA Cell DNA Interaction
25%
Adeno Associated Virus
25%
Deep Sequencing
18%
Genome Editing
18%
Immune Response
14%
Transcription Factor
14%
Clinical Trial
14%
Binding Site
14%
Gene Expression
12%
Dideoxynucleotide Sequencing
12%
Exon
12%
Codon
9%
Follistatin
8%
Genetic Transcription
8%
Programmed Cell Death
8%
Dystrophin
8%
Double-Strand DNA Break
8%
Primer Extension
8%
Macrophage
8%
DNA Sequence
8%
STAT1
8%
Zinc Finger Nuclease
6%
Target Cell
6%
T Cell
6%
Lentivirus Vector
6%
Insertional Mutagenesis
6%
Bioinformatics
6%
Blood Coagulation Factor
6%
Macaca fascicularis
6%
Gene Inactivation
6%
Capsid
6%
Coagulation Factor IX
6%
Medicine and Dentistry
Gene Therapy
75%
Haemophilia A
45%
Factor IX
44%
Haemophilia B
43%
Adeno Associated Virus Vector
36%
Hemophilia Gene Therapy
33%
Clustered Regularly Interspaced Short Palindromic Repeat
33%
Blood Clotting Factor
29%
Macrophage
25%
Neoplasm
25%
Tumor
25%
Cas9
25%
Transgene
20%
Gene Targeting
16%
Hepatocyte
16%
Guide RNA
15%
Target Cell
12%
Codon
11%
Combination Therapy
11%
Indel Mutation
10%
Exon
10%
Genome Editing
10%
Liver Toxicity
8%
Mutagenesis
8%
Immune Response
8%
Virus Capsid
8%
Zinc Finger Nuclease
8%
Immunosuppressive Treatment
8%
T-Cell Response
8%
Clinical Trial
8%
Lentivirus Vector
8%
Diseases
8%
Somatics
5%
Promoter Region
5%
Bleeding
5%
Nuclease
5%
Sanger Sequencing
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adeno Associated Virus Vector
56%
Haemophilia A
50%
Gene Delivery
41%
Blood Clotting Factor
40%
Blood Clotting Factor 9
33%
Adeno Associated Virus
28%
Combination Therapy
20%
Guide RNA
16%
Binding Site
12%
Transcription Factor
12%
Non-Viral Vector
12%
Macaca fascicularis
12%
Double Stranded DNA
8%
Hepatotoxicity
8%
Clinical Trial
8%
Mutagenesis
8%
Zinc Finger Nuclease
8%
Diseases
8%
Lentivirus Vector
8%
Haemophilia B
6%
